InsiderInsights.com Daily Round Up: 7/9/14

|
 |  Includes: ASH, BCRH, CRM, FB, FIVE, GBIM, HBI, LFUS, LTS, MERC, NERV, OPK, PCI, PDI, PML, RP, SYK, VG, ZNGA
by: InsiderInsights

Summary

Tables of the top insider purchases and sales filed with the SEC on Wednesday, July 9, 2014, based on dollar value.

Dollar values often do not equate with significance when it comes to insider trades.

Proprietary Insider Company Ratings are further given for selected companies.

I cannot repeat enough that dollar value is only one metric to assess the significance of an insider transaction. InsiderInsights calculates Insider Filer Statistics in real time, and formulates Insider Company Ratings based on numerous behavioral factors, so our clients can separate real investment intelligence from time-wasting noise.

On Today's Tables:

Insider trades were rated Significant at:

  • RealPage (NASDAQ:RP);
  • PIMCO Dynamic Credit Income Fund (NYSE:PCI);
  • PIMCO Dynamic Income Fund (NYSE:PDI);
  • Opko Health (NYSEMKT:OPK);
  • Ladenburg Thalmann Financial (NYSEMKT:LTS), and;
  • Mercer International (NASDAQ:MERC).

Insider trades were rated Nearly Significant at:

  • PIMCO Municipal Income Fund II (NYSE:PML);
  • Zynga (NASDAQ:ZNGA);
  • Five Below (NASDAQ:FIVE), and;
  • Blue Capital Reinsurance (NYSE:BCRH).

Insider trades were considered Insignificant at:

  • Facebook (NASDAQ:FB);
  • Ashland (NYSE:ASH);
  • Hanesbrands (NYSE:HBI);
  • Littelfuse (NASDAQ:LFUS), and;
  • Vonage Holdings (NYSE:VG).;
  • Salesforce.com (NYSE:CRM), and;
  • Stryker Corporation (NYSE:SYK).

Insider Purchases at Minerva Neurosciences (NASDAQ:NERV) and GlobeImmune (NASDAQ:GBIM) were associated with recent IPOs, and it's difficult to garner investment intelligence from transactions by insiders in unseasoned shares.

For more on how to profit from our Daily Round Up tables and analyze insider data, see references below.

Insider Purchases
#: Filer Name Insider Titles Company Name Ticker Trans
Type
Dollar Value
1 Index Venture BO Minerva Neurosciences NERV JB* $9,724,998
2 Care Capital Iii BO Minerva Neurosciences NERV JB* $4,425,000
3 Gross William H O Pimco DC Inc Fd PCI B $2,400,733
4 Morgenthaler Parti BO Globeimmune GBIM JB* $1,300,000
5 Gross William H O Pimco Mu Inc Fd II PML B $756,142
6 Montpelier Re BO Blue Capital Re BCRH B $707,215
7 Kellogg Peter R BO Mercer Intl MERC B $355,991
8 Frost Phillip Md CEO,CB,BO Opko Health OPK B,JB* $257,503
9 Gilinski Saul DIR Ladenburg Thalmann LTS B $141,300
10 Gross William H O Pimco Dyn Inc Fd PDI B $74,921
Click to enlarge

Source: InsiderInsights.com | Key to Insider Title and Trans Type Codes:
B=Open-market Buy; AB=10b5-1 (automatic) Buy; JB*=Buy indicated as being open-market, but not confirmed by trading price range and volume for the session.

Insider Sales
#: Filer Name Insider Titles Company Name Ticker Trans
Type
Dollar Value
1 Obrien James J Ky CEO Ashland ASH AS $17,403,388
2 Mattrick Donald A CEO,DIR Zynga ZNGA S $6,478,852
3 Schlessinger David CB,DIR Five Below FIVE AS $3,723,810
4 Benioff Marc CB,CEO Salesforce Com CRM AS $3,349,569
5 Noll Richard A CEO,DIR Hanesbrands HBI AS $2,909,402
6 Hunter Gordon CB,CEO,DIR Littelfuse LFUS AS $1,652,057
7 Winn Stephen T CB,CEO,BO Realpage RP AS $1,558,550
8 Citron Jeffrey A DIR,BO Vonage VG AS $1,490,964
9 Schroepfer Michael CTO Facebook FB AS $1,301,200
10 Stryker Ronda E DIR Stryker SYK AS $1,175,120
Click to enlarge

InsiderInsights.com | Key to Insider Title and Trans Type Codes :
S =Open-market Sale; AS=10b5-1 (automatic) Sale; JS*=Sale indicated as being open-market, but not confirmed by trading price range and volume for the session.

Did you miss our Previous Daily Round Up?

An important note from Jonathan Moreland, founder of InsiderInsights.com:

In a victory for common sense, it's been proven profitable -- by both academic studies and (more importantly) the experience of your fellow professional investors -- to monitor the trading behavior of company executives, directors, and large shareholders in the stocks of firms of which they're registered as "insiders".

Please note, however, that the lists above are strictly factual; they are not buy and sell recommendations.

At InsiderInsights.com, our clients find new investment ideas every day using more intricate insider screens to determine where they should focus their subsequent fundamental and technical analysis. And while stocks don't (or shouldn't) move up or down based on insider activity alone, insiders tend to be profitable indicators of when real stock-moving events like earnings surprises, corporate actions, and new products may be in the offing.

So use these daily articles as the initial research tools they are meant to be, and click the links in the tables to analyze a company's or insider's full insider history. Also feel free to email us with any questions on our proprietary insider data, filer statistics, and company ratings.

I should also relay that you could have seen the trades on today's Daily Round Up tables within hours of being filed, by signing up for our Free Intra-Day Top Trades Alerts.

Disclosure: The author has no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. The author wrote this article themselves, and it expresses their own opinions. The author is not receiving compensation for it (other than from Seeking Alpha). The author has no business relationship with any company whose stock is mentioned in this article.